NCT00237224View on ClinicalTrials.gov

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

February 28, 2007

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

Trial Locations (1)

Unknown

Novartis Investigative Site, Guadalajara

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY